(-0.09%) 5 464.47 points
(0.06%) 39 134 points
(0.15%) 17 744 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.81%) $2 311.90
(-0.06%) $28.85
(3.28%) $1 018.80
(0.35%) $0.936
(0.75%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
0.00% $ 0.00860
Live Chart Being Loaded With Signals
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation...
Stats | |
---|---|
Volumen de hoy | 23 683 |
Volumen promedio | 438 |
Capitalización de mercado | 192 605 |
EPS | $-0.290 ( Q2 | 2023-08-18 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | 2014 Kif-sbi It Investment Fund | Sell | 167 600 | Common Stock |
2023-09-27 | Lamond Stephen J | Buy | 2 600 | Common Stock |
2023-09-26 | Lamond Stephen J | Buy | 3 000 | Common Stock |
2023-09-18 | Lamond Stephen J | Buy | 2 500 | Common Stock |
2023-09-15 | Lamond Stephen J | Buy | 11 750 | Common Stock |
INSIDER POWER |
---|
30.32 |
Last 36 transactions |
Buy: 4 014 898 | Sell: 1 875 933 |
Peak Bio, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Peak Bio, Inc. Finanzas
Annual | 2022 |
Ingresos: | $607 681 |
Beneficio Bruto: | $607 572 (99.98 %) |
EPS: | $-0.740 |
FY | 2022 |
Ingresos: | $607 681 |
Beneficio Bruto: | $607 572 (99.98 %) |
EPS: | $-0.740 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Peak Bio, Inc.
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company\'s proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico